Brief: Cipher Pharmaceuticals Receives Successful Arbitration Award
14/10/2025 12:47
Oct 14 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO: CIPHER PHARMACEUTICALS RECEIVES SUCCESSFUL ARBITRATION AWARD CIPHER PHARMACEUTICALS INC - RECEIVES FAVORABLE ARBITRATION AWARD IN DISPUTE WITH SUN PHARMACEUTICALS INDUSTRIES CIPHER PHARMACEUTICALS INC - ARBITRATOR DECLARES CIPHER OWNER OF DISPUTED CLINICAL DATA Source text: ID:nCNW8fWQJa Further company coverage: CPH.TO
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million